A method for establishing a concurrent cataract mouse model
By knocking out the Phb2 gene in the mouse retina using CRISPR/Cas9 gene editing technology, the Phb2flox/flox;Six3-Cre mouse model was constructed, which solved the problems of insufficient etiological simulation and reproducibility of existing models, and realized the effective simulation of concurrent cataracts and the exploration of treatment strategies.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHONGSHAN OPHTHALMIC CENT SUN YAT SEN UNIV
- Filing Date
- 2025-04-21
- Publication Date
- 2026-07-03
AI Technical Summary
Existing animal models of concurrent cataracts are insufficient in terms of etiological simulation, reproducibility, and clinical relevance. They are difficult to effectively simulate chronic inflammatory processes such as uveitis or cataracts related to metabolic diseases. Furthermore, the procedures are complex and the success rate is greatly affected by the surgeon's experience.
Phb2flox/flox;Six3-Cre mouse models were constructed by knocking out the Phb2 gene in the mouse retina using CRISPR/Cas9 gene editing technology, which simulated the pathogenesis and pathological characteristics of human complicated cataracts.
This study provides an experimental model that is similar to the clinical phenotype of complicated cataracts, which can be used to study the pathogenesis of complicated cataracts and explore treatment strategies, providing theoretical basis and experimental support for clinical treatment.
Smart Images

Figure CN120304360B_ABST